1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow SHR-A2102: new trials by email Literature Review of SHR-A2102 trials Research Report on SHR-A2102
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316) SHR-A2102, Adebrelimab, Gemcitabine Hydrochloride for Injection - Muscular Invasive Bladder Cancer (MIBC) | Phase 2 / Phase 3 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 740 | 2025-04-25 | 2026-11-12 |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1)
China (1)